Key facts
- Goodpath’s last known valuation is $41.0M (Dec 2025).
- It has raised $22.0M; the latest was Later Stage VC ($18.0M) in Dec 2025.
- Notable investors include Alumni Ventures, Global Founders Capital, City Light Capital, MassMutual Ventures, Endeavor Greece — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Goodpath
- ·The full record, as it builds
Funding rounds
No funding rounds for Goodpath are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Goodpath
Developer of a personalized self-care program designed to improve the lives of people managing chronic conditions. The company bases its programs on lifestyle and health history that include nutrition and supplements, fitness, mindfulness, and guidance, enabling employees to follow doctor-approved treatments and achieve better health outcomes.
- Sector
- Healthcare
- HQ
- Cambridge, MA, United States
- Founded
- 2018
- Employees
- 23
- Website
- goodpath.com/
- Ownership
- Privately Held (backing)
Goodpath doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Goodpath shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Goodpath in its N-PORT filings yet. We sweep new filings monthly.